391 related articles for article (PubMed ID: 8627177)
21. Comparative analyses of megakaryocytes derived from cord blood and bone marrow.
Miyazaki R; Ogata H; Iguchi T; Sogo S; Kushida T; Ito T; Inaba M; Ikehara S; Kobayashi Y
Br J Haematol; 2000 Mar; 108(3):602-9. PubMed ID: 10759720
[TBL] [Abstract][Full Text] [Related]
22. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
[TBL] [Abstract][Full Text] [Related]
23. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
24. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
25. Secretion of a unique peptide from interleukin-2-stimulated natural killer cells that induces endomitosis in immature human megakaryocytes.
Angchaisuksiri P; Grigus SR; Carlson PL; Krystal GW; Dessypris EN
Blood; 2002 Jan; 99(1):130-6. PubMed ID: 11756162
[TBL] [Abstract][Full Text] [Related]
26. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
Alexander WS
Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the presence of murine primitive megakaryocytopoiesis in the early yolk sac.
Xu M J; Matsuoka S; Yang FC; Ebihara Y; Manabe A; Tanaka R; Eguchi M; Asano S; Nakahata T; Tsuji K
Blood; 2001 Apr; 97(7):2016-22. PubMed ID: 11264166
[TBL] [Abstract][Full Text] [Related]
28. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
29. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
Rojnuckarin P; Drachman JG; Kaushansky K
Blood; 1999 Aug; 94(4):1273-82. PubMed ID: 10438715
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin and its receptor.
Wendling F; Vainchenker W
Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
[TBL] [Abstract][Full Text] [Related]
31. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
32. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB
Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430
[TBL] [Abstract][Full Text] [Related]
33. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production.
Ishida Y; Ito T; Kuriya Si
J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494
[TBL] [Abstract][Full Text] [Related]
34. Thrombopoietin signaling is required for in vivo expansion of IL-11--responsive hematopoietic progenitor cells in the steady state.
Scott CL; Robb L; Nandurkar HH; Mansfield R; Alexander WS; Begley CG
Exp Hematol; 2001 Feb; 29(2):138-45. PubMed ID: 11166452
[TBL] [Abstract][Full Text] [Related]
35. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
36. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro.
Borge OJ; Ramsfjell V; Veiby OP; Murphy MJ; Lok S; Jacobsen SE
Blood; 1996 Oct; 88(8):2859-70. PubMed ID: 8874182
[TBL] [Abstract][Full Text] [Related]
40. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
Mintern J; Williams N; Jackson H
Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
